Literature DB >> 9651924

A protective role for IL-6 during early infection with Toxoplasma gondii.

H Jebbari1, C W Roberts, D J Ferguson, H Bluethmann, J Alexander.   

Abstract

IL-6 deficient mice were found to be significantly more susceptible to peroral infection with Toxoplasma gondii than their wild-type counterparts as measured by survival, brain cyst burdens and brain pathology at 28 days post infection. The physical manifestations of disease, such as weight loss, were not observed in IL-6 deficient animals until at least seven days later than such changes occurred in wildtype mice. During this early stage of infection IL-6+/+ but not IL-6-/- mice mounted a peripheral blood neutrophilia. Furthermore, between 6-8 days post-infection there was a significant increase in plasma IFN-gamma levels in wild-type but not IL-6 deficient mice. Not until days 18-23 post-infection, concurrent with the majority of deaths in IL-6-/- mice, were plasma IFN-gamma levels substantially and significantly raised in IL-6-/- mice. At this time not only were these plasma IFN-gamma levels 20-fold higher than background but eight-fold greater than peak (6-8 days post-infection) IFN-gamma levels in IL-6+/+ mice. IFN-gamma dependent parasite specific IgG2a levels were also significantly higher in IL-6-/- mice over this period and thereafter. Overall the evidence suggests that in the absence of IL-6 mice are unable to initiate a rapid proinflammatory response against T. gondii, which allows increased parasite growth. Increased mortality in IL-6-/- mice may be directly due to this increased parasite burden and the excessive inflammatory response this induces three weeks post-infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9651924     DOI: 10.1046/j.1365-3024.1998.00152.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  34 in total

1.  Differential infectivity and division of Toxoplasma gondii in human peripheral blood leukocytes.

Authors:  J Y Channon; R M Seguin; L H Kasper
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

2.  Neutrophil depletion during Toxoplasma gondii infection leads to impaired immunity and lethal systemic pathology.

Authors:  S K Bliss; L C Gavrilescu; A Alcaraz; E Y Denkers
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Stromal-derived IL-6 alters the balance of myeloerythroid progenitors during Toxoplasma gondii infection.

Authors:  David B Chou; Brian Sworder; Nicolas Bouladoux; Cindy N Roy; Amiko M Uchida; Michael Grigg; Pamela G Robey; Yasmine Belkaid
Journal:  J Leukoc Biol       Date:  2012-04-09       Impact factor: 4.962

4.  IL-1R Regulates Disease Tolerance and Cachexia in Toxoplasma gondii Infection.

Authors:  Stephanie J Melchor; Claire M Saunders; Imani Sanders; Jessica A Hatter; Kari A Byrnes; Sheryl Coutermarsh-Ott; Sarah E Ewald
Journal:  J Immunol       Date:  2020-04-29       Impact factor: 5.422

Review 5.  The molecular biology and immune control of chronic Toxoplasma gondii infection.

Authors:  Xiao-Yu Zhao; Sarah E Ewald
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

6.  Acanthamoeba Activates Macrophages Predominantly through Toll-Like Receptor 4- and MyD88-Dependent Mechanisms To Induce Interleukin-12 (IL-12) and IL-6.

Authors:  Antonella Cano; Antonella Mattana; Stuart Woods; Fiona L Henriquez; James Alexander; Craig W Roberts
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

7.  Early recognized antigen (p34) of Toxoplasma gondii after peroral ingestion of tissue cyst forming strain (Me49 strain) in mice.

Authors:  Y K Park; H W Nam
Journal:  Korean J Parasitol       Date:  1999-09       Impact factor: 1.341

8.  IL-6 mediates the susceptibility of glycoprotein 130 hypermorphs to Toxoplasma gondii.

Authors:  Jonathan S Silver; Jason S Stumhofer; Sara Passos; Matthias Ernst; Christopher A Hunter
Journal:  J Immunol       Date:  2011-05-23       Impact factor: 5.422

9.  IL-6 promotes NK cell production of IL-17 during toxoplasmosis.

Authors:  Sara T Passos; Jonathan S Silver; Aisling C O'Hara; David Sehy; Jason S Stumhofer; Christopher A Hunter
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

10.  Impact of Interleukin-27p28 on T and B Cell Responses during Toxoplasmosis.

Authors:  Jeongho Park; Jonathan H DeLong; James J Knox; Christoph Konradt; Elia D Tait Wojno; Christopher A Hunter
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.